NATCAPSUQBSENatural Capsules LtdHighNeutral
Announced Wed, 27 May · 20:15 IST

Please find attached the Financial Results for FY ended on March 31, 2026

Management Changes View source PDF

NATCAPSUQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-7.1%1-day move
₹169.99
prior close
₹160.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.7+2.5+2.5+1.5-7.1-7.8-7.1-8.6-7.3-8.2-5.3-10.4
Up moveDown movePending
AI summary

Natural Capsules Limited reported FY2026 standalone net profit of Rs.1,121.39 lakhs, up 67.1% from Rs.671.11 lakhs in FY2025, with revenue from operations at Rs.17,377.09 lakhs. Consolidated profit stood at Rs.1,707.36 lakhs. The Board approved re-appointment of Whole-time Director Mr. Laxminarayan Moondra for 3 years (effective July 28, 2026, subject to shareholder approval), appointed M/s. Mallya & Mallya as Internal Auditor for FY2026-27, and appointed Mr. Akshay Dutta as Company Secretary & Compliance Officer effective May 27, 2026. The company also allotted 25,000 equity shares under ESOP 2025 at Rs.10 per share, increasing paid-up capital to Rs.10,41,11,540. Auditors P. Chandrasekar LLP issued an unmodified opinion. One manufacturing unit was temporarily shut from December 26 to January 30, 2026 due to regulatory issues.

Likely market impact

Strong financial performance with 67% profit growth; ESOP allotment and management appointments are routine. No governance red flags detected.